ID Database Citation
hsa05218 KEGG Pathway
19718025 Pubmed "Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4. Prickett TD, Agrawal NS, Wei X, Yates KE, Lin JC, Wunderlich JR, et al. Nat Genet. 2009 Oct;41(10):1127–32. PubMed Europe PMC Scholia"
21946352 Pubmed "Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma. Prickett TD, Wei X, Cardenas-Navia I, Teer JK, Lin JC, Walia V, et al. Nat Genet. 2011 Sep 25;43(11):1119–26. PubMed Europe PMC Scholia"
22453014 Pubmed "Therapeutic implications of KIT in melanoma. Postow MA, Carvajal RD. Cancer J. 2012;18(2):137–41. PubMed Europe PMC Scholia"
22622578 Pubmed "Melanoma genome sequencing reveals frequent PREX2 mutations. Berger MF, Hodis E, Heffernan TP, Deribe YL, Lawrence MS, Protopopov A, et al. Nature. 2012 May 9;485(7399):502–6. PubMed Europe PMC Scholia"
22817889 Pubmed "A landscape of driver mutations in melanoma. Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP, et al. Cell. 2012 Jul 20;150(2):251–63. PubMed Europe PMC Scholia"
22842228 Pubmed "Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, et al. Nat Genet. 2012 Sep;44(9):1006–14. PubMed Europe PMC Scholia"
26091043 Pubmed "Genomic Classification of Cutaneous Melanoma. Cancer Genome Atlas Network. Cell. 2015 Jun 18;161(7):1681–96. PubMed Europe PMC Scholia"
30987166 Pubmed "Modelling of Protein Kinase Signaling Pathways in Melanoma and Other Cancers. Kunz M, Vera J. Cancers (Basel). 2019 Apr 3;11(4):465. PubMed Europe PMC Scholia"